{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T19:04:28Z","timestamp":1775070268434,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171918"],"award-info":[{"award-number":["82171918"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Insights Imaging"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>To apply cardiac magnetic resonance imaging (CMR) for detailed myocardial characterization in uremic cardiomyopathy (UC), hypertensive cardiomyopathy (HTN), and hypertrophic cardiomyopathy (HCM) aiming to enrich the understanding of UC\u2019s etiology and further support the development of therapeutic strategies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 152 patients (age: 49.2\u2009\u00b1\u20099.9 years; 65.8% male) underwent routine CMR from June 2016 to March 2023. Retrospectively, 53 patients with UC, 39 patients with HTN, 30 patients with HCM, and 30 healthy controls were included. Functional analysis, feature tracking of the left ventricle and left atrium, and myocardial T1, T2, and T2* mapping were performed. Statistical analysis included Pearson correlation and ROC analysis to define correlations and discriminators between groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>UC patients demonstrated significantly higher native T1 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001 for all) and T2 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.002 for all) values compared with the other three groups. UC patients revealed higher left atrial reservoir strain rate (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001 for all) and left atrial conduit strain rate (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001 for all) absolute values as compared with HTN and HCM patients. A significant correlation between T1 and T2 values in UC patients (<jats:italic>r<\/jats:italic>\u2009=\u20090.511, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) was found. The combination of T1 values and strain parameters was the best discriminator between UC and HTN patients (AUC\u2009=\u20090.872, 95% CI: 0.801\u20130.943) and between UC and HCM patients (AUC\u2009=\u20090.840, 95% CI: 0.746\u20130.934).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>UC reveals distinguishing tissue characteristics as evidenced by T1 and T2 mapping, as well as distinguishing functional strain parameters as compared with other hypertrophic phenotypes such as HTN and HCM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Critical relevance statement<\/jats:title>\n                <jats:p>The use of CMR imaging in UC patients offers incremental information to elucidate its complex etiology, contributing to ongoing discourse on effective treatment pathways.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Key Points<\/jats:title>\n                <jats:p><jats:list list-type=\"bullet\">\n                  <jats:list-item>\n                    <jats:p>This study investigated uremic, hypertensive, and hypertrophic cardiomyopathies using cardiac MRI.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>UC patients have higher T1 and T2 values and better preserved cardiac function.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>Combined strain and T1 values distinguish UC from other cardiomyopathies.<\/jats:p>\n                  <\/jats:list-item>\n                <\/jats:list><\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s13244-024-01770-0","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T16:02:20Z","timestamp":1722528140000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Myocardial hypertrophy: the differentiation of uremic, hypertensive, and hypertrophic cardiomyopathies by cardiac MRI"],"prefix":"10.1186","volume":"15","author":[{"given":"Zhaoxin","family":"Tian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiqi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaibi","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaodi","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shutong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinuo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zequn","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0516-6996","authenticated-orcid":false,"given":"Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,1]]},"reference":[{"key":"1770_CR1","doi-asserted-by":"publisher","first-page":"414","DOI":"10.2471\/BLT.17.206441","volume":"96","author":"VA Luyckx","year":"2018","unstructured":"Luyckx VA, Tonelli M, Stanifer JW (2018) The global burden of kidney disease and the sustainable development goals. Bull World Health Organ 96:414\u2013422D","journal-title":"Bull World Health Organ"},{"key":"1770_CR2","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","volume":"388","author":"GBD 2015 Mortality and Causes of Death Collaborators","year":"2016","unstructured":"GBD 2015 Mortality and Causes of Death Collaborators (2016) Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388:1459\u20131544","journal-title":"Lancet"},{"key":"1770_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nrneph.2010.191","volume":"7","author":"MK Shamseddin","year":"2011","unstructured":"Shamseddin MK, Parfrey PS (2011) Sudden cardiac death in chronic kidney disease: epidemiology and prevention. Nat Rev Nephrol 7:145\u2013154","journal-title":"Nat Rev Nephrol"},{"key":"1770_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2022.905759","volume":"9","author":"D Ma","year":"2022","unstructured":"Ma D, Mandour AS, Elfadadny A et al (2022) Changes in cardiac function during the development of uremic cardiomyopathy and the effect of salvianolic acid B administration in a rat model. Front Vet Sci 9:905759","journal-title":"Front Vet Sci"},{"key":"1770_CR5","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3390\/biom13050773","volume":"13","author":"SC Valbuena-L\u00f3pez","year":"2023","unstructured":"Valbuena-L\u00f3pez SC, Camastra G, Cacciotti L et al (2023) Cardiac imaging biomarkers in chronic kidney disease. Biomolecules 13:773","journal-title":"Biomolecules"},{"key":"1770_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jcmg.2015.11.005","volume":"9","author":"AJ Taylor","year":"2016","unstructured":"Taylor AJ, Salerno M, Dharmakumar R, Jerosch-Herold M (2016) T1 mapping: basic techniques and clinical applications. JACC Cardiovasc Imaging 9:67\u201381","journal-title":"JACC Cardiovasc Imaging"},{"key":"1770_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","volume":"19","author":"DR Messroghli","year":"2017","unstructured":"Messroghli DR, Moon JC, Ferreira VM et al (2017) Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson 19:75","journal-title":"J Cardiovasc Magn Reson"},{"key":"1770_CR8","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1161\/CIRCULATIONAHA.110.007641","volume":"123","author":"J-P Carpenter","year":"2011","unstructured":"Carpenter J-P, He T, Kirk P et al (2011) On T2* magnetic resonance and cardiac iron. Circulation 123:1519\u20131528","journal-title":"Circulation"},{"key":"1770_CR9","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1161\/CIRCIMAGING.112.000133","volume":"6","author":"A Kali","year":"2013","unstructured":"Kali A, Kumar A, Cokic I et al (2013) Chronic manifestation of postreperfusion intramyocardial hemorrhage as regional iron deposition: a cardiovascular magnetic resonance study with ex vivo validation. Circ Cardiovasc Imaging 6:218\u2013228","journal-title":"Circ Cardiovasc Imaging"},{"key":"1770_CR10","doi-asserted-by":"publisher","first-page":"5424","DOI":"10.1007\/s00330-022-08629-2","volume":"32","author":"J Xu","year":"2022","unstructured":"Xu J, Yang W, Zhao S, Lu M (2022) State-of-the-art myocardial strain by CMR feature tracking: clinical applications and future perspectives. Eur Radiol 32:5424\u20135435","journal-title":"Eur Radiol"},{"key":"1770_CR11","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1007\/s00392-021-01848-5","volume":"110","author":"E Cavus","year":"2021","unstructured":"Cavus E, Muellerleile K, Schellert S et al (2021) CMR feature tracking strain patterns and their association with circulating cardiac biomarkers in patients with hypertrophic cardiomyopathy. Clin Res Cardiol 110:1757\u20131769","journal-title":"Clin Res Cardiol"},{"key":"1770_CR12","doi-asserted-by":"publisher","first-page":"e0221061","DOI":"10.1371\/journal.pone.0221061","volume":"14","author":"U Neisius","year":"2019","unstructured":"Neisius U, Myerson L, Fahmy AS et al (2019) Cardiovascular magnetic resonance feature tracking strain analysis for discrimination between hypertensive heart disease and hypertrophic cardiomyopathy. PLoS One 14:e0221061","journal-title":"PLoS One"},{"key":"1770_CR13","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s10554-020-01806-8","volume":"36","author":"SA Nazir","year":"2020","unstructured":"Nazir SA, Shetye AM, Khan JN et al (2020) Inter-study repeatability of circumferential strain and diastolic strain rate by CMR tagging, feature tracking and tissue tracking in ST-segment elevation myocardial infarction. Int J Cardiovasc Imaging 36:1133\u20131146","journal-title":"Int J Cardiovasc Imaging"},{"key":"1770_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jacbts.2020.01.005","volume":"5","author":"CC Sucharov","year":"2020","unstructured":"Sucharov CC (2020) Paracrine factors in uremic cardiomyopathy. JACC Basic Transl Sci 5:167\u2013168","journal-title":"JACC Basic Transl Sci"},{"key":"1770_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3390\/toxins12030161","volume":"12","author":"N Kaesler","year":"2020","unstructured":"Kaesler N, Babler A, Floege J, Kramann R (2020) Cardiac remodeling in chronic kidney disease. Toxins 12:161","journal-title":"Toxins"},{"key":"1770_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12968-020-00683-3","volume":"22","author":"N Kawel-Boehm","year":"2020","unstructured":"Kawel-Boehm N, Hetzel SJ, Ambale-Venkatesh B et al (2020) Reference ranges (\u201cnormal values\u201d) for cardiovascular magnetic resonance (CMR) in adults and children: 2020 update. J Cardiovasc Magn Reson 22:87","journal-title":"J Cardiovasc Magn Reson"},{"key":"1770_CR17","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/jama.2019.14745","volume":"322","author":"TK Chen","year":"2019","unstructured":"Chen TK, Knicely DH, Grams ME (2019) Chronic kidney disease diagnosis and management: a review. JAMA 322:1294\u20131304","journal-title":"JAMA"},{"key":"1770_CR18","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","volume":"31","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K et al (2013) 2013 ESH\/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 31:1281\u20131357","journal-title":"J Hypertens"},{"key":"1770_CR19","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS et al (2018) 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 71:e127\u2013e248","journal-title":"J Am Coll Cardiol"},{"key":"1770_CR20","first-page":"182","volume":"16","author":"Joint Committee for Guideline Revision","year":"2019","unstructured":"Joint Committee for Guideline Revision (2019) 2018 Chinese guidelines for prevention and treatment of hypertension\u2014a report of the revision committee of Chinese guidelines for prevention and treatment of hypertension. J Geriatr Cardiol 16:182\u2013241","journal-title":"J Geriatr Cardiol"},{"key":"1770_CR21","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s10741-019-09775-4","volume":"24","author":"G Makavos","year":"2019","unstructured":"Makavos G, \u039aairis C, Tselegkidi M-E et al (2019) Hypertrophic cardiomyopathy: an updated review on diagnosis, prognosis, and treatment. Heart Fail Rev 24:439\u2013459","journal-title":"Heart Fail Rev"},{"key":"1770_CR22","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3390\/diagnostics12051022","volume":"12","author":"F Baessato","year":"2022","unstructured":"Baessato F, Romeo C, Rabbat MG et al (2022) A comprehensive assessment of cardiomyopathies through cardiovascular magnetic resonance: focus on the pediatric population. Diagnostics 12:1022","journal-title":"Diagnostics"},{"key":"1770_CR23","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","volume":"35","author":"PM Elliott","year":"2014","unstructured":"Authors\/Task Force members, Elliott PM, Anastasakis A et al (2014) 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 35:2733\u20132779","journal-title":"Eur Heart J"},{"key":"1770_CR24","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.21037\/qims-22-793","volume":"13","author":"H Li","year":"2023","unstructured":"Li H, Zheng Y, Peng X et al (2023) Heart failure with preserved ejection fraction in post myocardial infarction patients: a myocardial magnetic resonance (MR) tissue tracking study. Quant Imaging Med Surg 13:1723\u20131739","journal-title":"Quant Imaging Med Surg"},{"key":"1770_CR25","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.jcmg.2017.08.005","volume":"10","author":"AR Patel","year":"2017","unstructured":"Patel AR, Kramer CM (2017) Role of cardiac magnetic resonance in the diagnosis and prognosis of nonischemic cardiomyopathy. JACC Cardiovasc Imaging 10:1180\u20131193","journal-title":"JACC Cardiovasc Imaging"},{"key":"1770_CR26","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ijcard.2020.03.002","volume":"306","author":"L Arcari","year":"2020","unstructured":"Arcari L, Hinojar R, Engel J et al (2020) Native T1 and T2 provide distinctive signatures in hypertrophic cardiac conditions\u2014comparison of uremic, hypertensive and hypertrophic cardiomyopathy. Int J Cardiol 306:102\u2013108","journal-title":"Int J Cardiol"},{"key":"1770_CR27","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1007\/s11547-020-01276-x","volume":"125","author":"S Pradella","year":"2020","unstructured":"Pradella S, Grazzini G, De Amicis C et al (2020) Cardiac magnetic resonance in hypertrophic and dilated cardiomyopathies. Radiol Med 125:1056\u20131071","journal-title":"Radiol Med"},{"key":"1770_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-37845-4","volume":"9","author":"T Kotecha","year":"2019","unstructured":"Kotecha T, Martinez-Naharro A, Yoowannakul S et al (2019) Acute changes in cardiac structural and tissue characterisation parameters following haemodialysis measured using cardiovascular magnetic resonance. Sci Rep 9:1388","journal-title":"Sci Rep"},{"key":"1770_CR29","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.jacc.2019.01.059","volume":"73","author":"L Thomas","year":"2019","unstructured":"Thomas L, Marwick TH, Popescu BA et al (2019) Left atrial structure and function, and left ventricular diastolic dysfunction: JACC state-of-the-art review. J Am Coll Cardiol 73:1961\u20131977","journal-title":"J Am Coll Cardiol"},{"key":"1770_CR30","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1002\/ehf2.12820","volume":"7","author":"A Frydas","year":"2020","unstructured":"Frydas A, Morris DA, Belyavskiy E et al (2020) Left atrial strain as sensitive marker of left ventricular diastolic dysfunction in heart failure. ESC Heart Fail 7:1956\u20131965","journal-title":"ESC Heart Fail"},{"key":"1770_CR31","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jacc.2013.10.055","volume":"63","author":"BD Hoit","year":"2014","unstructured":"Hoit BD (2014) Left atrial size and function: role in prognosis. J Am Coll Cardiol 63:493\u2013505","journal-title":"J Am Coll Cardiol"},{"key":"1770_CR32","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1161\/01.CIR.100.4.427","volume":"100","author":"P Barbier","year":"1999","unstructured":"Barbier P, Solomon SB, Schiller NB, Glantz SA (1999) Left atrial relaxation and left ventricular systolic function determine left atrial reservoir function. Circulation 100:427\u2013436","journal-title":"Circulation"},{"key":"1770_CR33","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ijcard.2016.06.197","volume":"220","author":"M Cameli","year":"2016","unstructured":"Cameli M, Mandoli GE, Loiacono F et al (2016) Left atrial strain: a useful index in atrial fibrillation. Int J Cardiol 220:208\u2013213","journal-title":"Int J Cardiol"},{"key":"1770_CR34","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.jcmg.2022.01.016","volume":"15","author":"AG Raafs","year":"2022","unstructured":"Raafs AG, Vos JL, Henkens MTHM et al (2022) Left atrial strain has superior prognostic value to ventricular function and delayed-enhancement in dilated cardiomyopathy. JACC Cardiovasc Imaging 15:1015\u20131026","journal-title":"JACC Cardiovasc Imaging"},{"key":"1770_CR35","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","volume":"44","author":"E Arbelo","year":"2023","unstructured":"Arbelo E, Protonotarios A, Gimeno JR et al (2023) 2023 ESC guidelines for the management of cardiomyopathies. Eur Heart J 44:3503\u20133626","journal-title":"Eur Heart J"},{"key":"1770_CR36","first-page":"e13","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS et al (2018) 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 71:e13\u2013e115","journal-title":"Hypertension"},{"key":"1770_CR37","doi-asserted-by":"publisher","first-page":"E40","DOI":"10.1111\/chf.12030","volume":"19","author":"E Alhaj","year":"2013","unstructured":"Alhaj E, Alhaj N, Rahman I, Niazi TO, Berkowitz R, Klapholz M (2013) Uremic cardiomyopathy: an underdiagnosed disease. Congest Heart Fail 19:E40\u2013E45","journal-title":"Congest Heart Fail"},{"key":"1770_CR38","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1093\/ckj\/sfac146","volume":"15","author":"PB Mark","year":"2022","unstructured":"Mark PB, Mangion K, Rankin AJ et al (2022) Left ventricular dysfunction with preserved ejection fraction: the most common left ventricular disorder in chronic kidney disease patients. Clin Kidney J 15:2186\u20132199","journal-title":"Clin Kidney J"},{"key":"1770_CR39","first-page":"e533","volume":"142","author":"SR Ommen","year":"2020","unstructured":"Ommen SR, Mital S, Burke MA et al (2020) 2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 142:e533\u2013e557","journal-title":"Circulation"}],"container-title":["Insights into Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-024-01770-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13244-024-01770-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-024-01770-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T16:05:12Z","timestamp":1722528312000},"score":1,"resource":{"primary":{"URL":"https:\/\/insightsimaging.springeropen.com\/articles\/10.1186\/s13244-024-01770-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1770"],"URL":"https:\/\/doi.org\/10.1186\/s13244-024-01770-0","relation":{},"ISSN":["1869-4101"],"issn-type":[{"value":"1869-4101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,1]]},"assertion":[{"value":"26 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institution and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study was approved by the ethics committee of the First Hospital of China Medical University (IRB number: KT2021213), and all subjects gave written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"190"}}